12-Week Study in Adult Subjects With Asthma

Summary

This will be a multi-center, randomized, placebo-controlled parallel-group study to evaluate nebulized fluticasone propionate (FP) dose response in adult subjects with partly controlled and uncontrolled asthma. Individual participation will be approximately 16 weeks, including 12 weeks of double-blind treatment.

Timeline

Start

2012-03

Primary completion

2013-11

Completion

2013-11

Drugs

Indications